Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob C Laister

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Expert Review of Hematology|April 7, 2022
An evaluation of pembrolizumab for classical Hodgkin lymphomaFarheen Manji, Rob C Laister, John Kuruvilla
Biomolecules|January 21, 2023
Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 InhibitorsKyla L Trkulja, Farheen Manji, John Kuruvilla, et al.
BMC Molecular Biology|August 6, 2011
Cruciform structures are a common DNA feature important for regulating biological processesVáclav Brázda, Rob C Laister, Eva B Jagelská, et al.
Hemasphere|August 23, 2024
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphomaInna Y Gong, Daisy Tran, Samuel Saibil, et al.
Molecular Cell|March 5, 2017
The SMX DNA Repair Tri-nucleaseHaley D M Wyatt, Rob C Laister, Stephen R Martin, et al.
Journal of Molecular Biology|May 1, 2012
Early steps in oxidation-induced SOD1 misfolding: implications for non-amyloid protein aggregation in familial ALSVikram Khipple Mulligan, Aaron Kerman, Rob C Laister, et al.
BMJ Open|January 29, 2018
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping reviewSamantha J Mayo, John Kuruvilla, Rob C Laister, et al.
Journal of Medicinal Chemistry|December 14, 2011
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activityBrent D G Page, Haytham Khoury, Rob C Laister, et al.
Nature Structural & Molecular Biology|December 2, 2008
Molecular basis of Pirh2-mediated p53 ubiquitylationYi Sheng, Rob C Laister, Alexander Lemak, et al.
The Journal of Biological Chemistry|May 13, 2011
CCM3/PDCD10 heterodimerizes with germinal center kinase III (GCKIII) proteins using a mechanism analogous to CCM3 homodimerizationDerek F Ceccarelli, Rob C Laister, Vikram Khipple Mulligan, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Review of Hematology|April 7, 2022
An evaluation of pembrolizumab for classical Hodgkin lymphomaFarheen Manji, Rob C Laister, John Kuruvilla
Biomolecules|January 21, 2023
Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 InhibitorsKyla L Trkulja, Farheen Manji, John Kuruvilla, et al.
BMC Molecular Biology|August 6, 2011
Cruciform structures are a common DNA feature important for regulating biological processesVáclav Brázda, Rob C Laister, Eva B Jagelská, et al.
Hemasphere|August 23, 2024
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphomaInna Y Gong, Daisy Tran, Samuel Saibil, et al.
Molecular Cell|March 5, 2017
The SMX DNA Repair Tri-nucleaseHaley D M Wyatt, Rob C Laister, Stephen R Martin, et al.
Journal of Molecular Biology|May 1, 2012
Early steps in oxidation-induced SOD1 misfolding: implications for non-amyloid protein aggregation in familial ALSVikram Khipple Mulligan, Aaron Kerman, Rob C Laister, et al.
BMJ Open|January 29, 2018
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping reviewSamantha J Mayo, John Kuruvilla, Rob C Laister, et al.
Journal of Medicinal Chemistry|December 14, 2011
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activityBrent D G Page, Haytham Khoury, Rob C Laister, et al.
Nature Structural & Molecular Biology|December 2, 2008
Molecular basis of Pirh2-mediated p53 ubiquitylationYi Sheng, Rob C Laister, Alexander Lemak, et al.
The Journal of Biological Chemistry|May 13, 2011
CCM3/PDCD10 heterodimerizes with germinal center kinase III (GCKIII) proteins using a mechanism analogous to CCM3 homodimerizationDerek F Ceccarelli, Rob C Laister, Vikram Khipple Mulligan, et al.
Pageof 3